Current through Register Vol. 49, No. 24, December 16, 2024
Section 20 CSR 2220-5.060 - Controlled Substance ReportingPURPOSE: This rule defines requirements for reporting the distribution of controlled substances from drug and pharmacy distributors to persons and facilities that are registered with the Federal Drug Enforcement Administration.
(1) Wholesale drug and pharmacy distributors that distribute Schedule II products and Schedule III narcotics Automation of Reports and Consolidated Orders (ARCOS products) shall provide a listing of those products distributed within the state to the board on a quarterly basis when requested to do so by the board. In addition, wholesale drug and pharmacy distributors that distribute controlled substances within the state shall provide up to a twenty-four (24) month retrospective listing of all controlled substances (Schedule II through Schedule IV) distributed within the state or to a specific location to the board when requested to do so by the board. The board shall submit the request thirty (30) days in advance of the information requested. Reports must be submitted to the board either on hard copy in typewritten form or by electronic media. If electronic media is used in providing the reports, it shall be provided in one (1) of the following formats. (A) If an electronic tape is used, it shall be an IBM 9-track, labeled or nonlabeled, 1600 or 6250 bits per inch (bpi);(B) If a diskette is used, it shall be either a MacIntosh 400K or 800K; MS-DOS 5 1/4" 360K or 1.2 meg; MS-DOS 3 1/2" 720K or 1.44 meg; or an IBM 8" diskette; or(C) If a cartridge is used, it shall be a 1/2" tape, 3480 Compatible. AUTHORITY: section 338.350, RSMo Supp. 1989.* This rule originally filed as 4 CSR 220-5.060. Original rule filed Jan. 3, 1992, effective Aug. 6, 1992. Moved to 20 CSR 2220-5.060, effective Aug. 28, 2006. *Original authority: 338.350, RSMo 1989.